The introduction of generic imatinib represents a substantial opportunity for patients battling chronic myeloid leukemia and other diseases. Original brand-name imatinib, often referred to as Gleevec, carries a steep https://generic-imatinib018851.p2blogs.com/41820472/common-sti571-a-cost-effective-choice